Integrated analysis of differentially m6A modified and expressed lncRNAs for biomarker identification in coronary artery disease
Cell Biology International · 2024
DOI: 10.1002/cbin.12224 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology International, 2024. Verfasst von Rongli Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric, The Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu Province, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Coronary Artery Disease, Biomarkers, Adenosine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Tibet Autonomous Region, National Natural Science Foundation of China.
Abstract (Originalsprache)
N6‐methyladenosine (m6A) is the most prevalent internal RNA modification in mammals. However, limited research has been conducted on the role of m6A in coronary artery disease (CAD). We conducted methylated RNA immunoprecipitation sequencing and RNA sequencing to obtain a genome‐wide profile of m6A‐modified long noncoding RNAs (lncRNAs) in human coronary artery smooth muscle cells either exposed to oxidized low‐density lipoprotein treatment or not, and the characteristics of the expression profiles were explored using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses. The predictive effects of seven selected lncRNAs on CAD were evaluated in peripheral blood mononuclear cells (PBMCs). The differentially m6A‐modified and expressed lncRNAs related genes were predominantly enriched in small GTPase‐mediated signal transduction, ErbB signaling, and Rap1 signaling. Additionally, the expression levels of uc003pes.1 , ENST00000422847 , and NR_110155 were significantly associated with CAD, with uc003pes.1 identified as an independent risk factor and NR_110155 as an independent protective factor for CAD. NR_110155 and uc003pes.1 in PBMCs have the potential to serve as biomarkers for predicting CAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatric, The Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu Province, China.
- Department of Cardiovascular Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.
- Department of Geriatric, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.
Förderung
- Natural Science Foundation of Tibet Autonomous Region
- National Natural Science Foundation of China
Zitieren
APA
Jiang, R., Jia, Q., Li, C., Gan, X., Zhou, Y., Pan, Y., Fu, Y., Chen, X., Liang, L., & Jia, E. (2024). Integrated analysis of differentially m6A modified and expressed lncRNAs for biomarker identification in coronary artery disease. Cell Biology International. https://doi.org/10.1002/cbin.12224
Vancouver
Jiang R, Jia Q, Li C, Gan X, Zhou Y, Pan Y, et al. Integrated analysis of differentially m6A modified and expressed lncRNAs for biomarker identification in coronary artery disease. Cell Biology International. 2024. doi:10.1002/cbin.12224
BibTeX
@article{Jiang2024,
author = {Jiang, Rongli and Jia, Qiaowei and Li, Chengcheng and Gan, Xiongkang and Zhou, Yaqing and Pan, Yang and Fu, Yahong and Chen, Xiumei and Liang, Lanyu and Jia, Enzhi},
title = {Integrated analysis of differentially m6A modified and expressed lncRNAs for biomarker identification in coronary artery disease},
journal = {Cell Biology International},
year = {2024},
doi = {10.1002/cbin.12224}
}
EUVIMED